Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids , INSYS is developing a pipeline of products intending to address unmet medical needs and the clinical shortcomings of existing commercial products. INSYS is committed to developing medications for … Read More
The post INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) Oral Solution for … appeared first on Dagga Magazine.